Burjeel Medical City provides specialised Cystolitholapaxy with a focus on precise stone fragmentation, effective removal of bladder stone fragments, preservation of urinary tract structures, and individualized postoperative urological care. Established in 2017, the ISO accredited hospital is located in Abu Dhabi, United Arab Emirates and operates 350 beds, with modern endourology, cystoscopy, laser technology, urinary imaging, and postoperative care infrastructure.

Cystolitholapaxy can provide an effective minimally invasive treatment option for appropriately selected patients with bladder stones. Treatment planning considers the number, size, and location of stones, urinary symptoms, bladder emptying function, recurrent infections, underlying causes of stone formation, and overall health. A detailed urological evaluation may also identify conditions such as bladder outlet obstruction or urinary retention that contributed to stone formation and may require additional management to reduce the risk of recurrence.